These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6433452)

  • 21. Controlled clinical trials with prothrombin complex concentrates.
    Lusher JM
    Prog Clin Biol Res; 1984; 150():277-90. PubMed ID: 6431433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor.
    Chavin SI; Siegel DM; Rocco TA; Olson JP
    Am J Med; 1988 Aug; 85(2):245-9. PubMed ID: 3135752
    [No Abstract]   [Full Text] [Related]  

  • 23. Life-threatening sublingual hematoma in a severely hemophilic patient with factor VIII inhibitor.
    Takeuchi M; Shikimori M; Kaneda T
    J Oral Maxillofac Surg; 1986 May; 44(5):401-3. PubMed ID: 3084733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. By what mechanisms could prothrombin complex concentrates promote factor VIII bypassing activity in vivo?
    Giles AR
    Transfus Med Rev; 1987 Aug; 1(2):131-7. PubMed ID: 2980270
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor.
    Karayalcin G; Goldberg B; Cherrick I; Kurer C; Bierman F; Lanzkowsky P
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):416-9. PubMed ID: 8214364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors in mild/moderate haemophilia A: an update.
    Franchini M; Salvagno GL; Lippi G
    Thromb Haemost; 2006 Aug; 96(2):113-8. PubMed ID: 16894451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prothrombin complex concentrates and inhibitors. A reappraisal.
    Kasper CK
    JAMA; 1984 Jan; 251(1):68-9. PubMed ID: 6418899
    [No Abstract]   [Full Text] [Related]  

  • 28. Activated prothrombin complex concentrates in the management of the hemophiliac with Factor VIII inhibitor: case report.
    Griffen AL; Hoots WK; Carter AB
    Pediatr Dent; 1987 Dec; 9(4):321-4. PubMed ID: 3148907
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of activated prothrombin complex concentrate over multiple surgical episodes in a hemophilic child with an inhibitor.
    Heisel MA; Gomperts ED; McComb JG; Hilgartner M
    J Pediatr; 1983 Jun; 102(6):951-4. PubMed ID: 6406656
    [No Abstract]   [Full Text] [Related]  

  • 30. Antihemophilic factor inhibitors. Management with prothrombin complex concentrates.
    Kelly P; Penner JA
    JAMA; 1976 Nov; 236(18):2061-4. PubMed ID: 989788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of the treatment of children with factor VIII inhibitors with prothrombin-complex concentrates.
    Ekert H; Smibert E; Exton J
    Med J Aust; 1987 Sep; 147(5):230-3. PubMed ID: 3118153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of inhibitors in patients with severe and moderate hemophilia A treated with factor VIII concentrates.
    Schwarzinger I; Pabinger I; Korninger C; Haschke F; Kundi M; Niessner H; Lechner K
    Am J Hematol; 1987 Mar; 24(3):241-5. PubMed ID: 3103425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Substitution therapy of hemorrhagic diseases].
    Haupt H
    Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of platelets on the in vitro response to prothrombin complex concentrates in F.VIII inhibitor plasma.
    Castaldi PA; Smith IL
    Pathology; 1980 Jan; 12(1):111-8. PubMed ID: 6769085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful immune tolerance induction with low-dose coagulation factor VIII in a patient with hemophilia A from a developing country.
    Ay Y; Ersin T; Yesim O; Hilkay KT; Dilek I; Gulcihan O; Ahmet K
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):729-31. PubMed ID: 26484639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of immune tolerance in hemophiliacs with inhibitors by combined treatment with i.v. IgG, cyclophosphamide and factor VIII or IX.
    Nilsson IM; Berntorp E
    Prog Clin Biol Res; 1990; 324():69-78. PubMed ID: 2106694
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hemophiliacs with inhibitor. Experience at the Center of Medical Action for Hemophilia of the S. José Hospital].
    Diniz MJ; Dias Francisco F; Tavares ML; Leal I
    Acta Med Port; 1992 Apr; 5(4):178-80. PubMed ID: 1605065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The management of bleeding in hemophilia.
    Abildgaard CF
    Adv Pediatr; 1969; 16():365-90. PubMed ID: 4899062
    [No Abstract]   [Full Text] [Related]  

  • 40. [Suppression of factor VIII inhibitor in children with hemophilia A].
    Zenz W; Muntean W
    Padiatr Padol; 1987; 22(4):345-52. PubMed ID: 3125510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.